SlideShare ist ein Scribd-Unternehmen logo
1 von 33
Diagnostic Journeys of Patients
Evaluated for Lyme Disease and
Given Extended Antibiotic Therapy
Yi-Ju Tseng, PhD
Computational Health Informatics Program (CHIP)
Boston Children’s Hospital, MA, USA

Dept. of Information Management, Chang Gung University, Taiwan
Co-authors: 

Alfred DeMaria Jr, Donald Goldmann, Kenneth Mandl*
AMIA 2016
S59: Podium Presentations
Using Data Science to address Clinical Problems
Research Target
2
Nelson CA. et al (2015). Incidence of Clinician-Diagnosed Lyme Disease,
United States, 2005–2010. Emerging Infectious Diseases, 21(9), 1625–1631
Research Target
2
Nelson CA. et al (2015). Incidence of Clinician-Diagnosed Lyme Disease,
United States, 2005–2010. Emerging Infectious Diseases, 21(9), 1625–1631
Only 25,000 reported cases in 2014
3
Standard treatment: 

2-4w antibiotic

↓

Persistent Symptom

↓

Post-treatment LD Syndrome
10~20%
4
Standard treatment: 

2-4w antibiotic

↓

Persistent Symptom

↓

Post-treatment LD Syndrome
10~20%
4
Narrative Matte
DOI: 10.1377/HLTHAFF.2011.0792
Chronic Lyme Disease:
It’s Time To Solve The
Medical Mystery Inside
An Enigma
Scientists and doctors disagree about whether there is such a condition
as “chronic” Lyme disease or “post–Lyme disease syndrome.” Americans
need the National Institutes of Health and basic science research to
help determine the answer.
BY LAURIE MCCLELLAN
acc
dis
A
Pat
gra
wa
bac
for
pac
pli
har
ma
isti
his
car
I
mi
he
wa
nap
got
the
kep
un
G
ho
tim
an
six
aro
to
fre
wa
wa
T
lat
ing
Nu
it h
wh
Pat
Jul
Standard treatment: 

2-4w antibiotic

↓

Persistent Symptom

↓

Post-treatment LD Syndrome
10~20%
4
What Happens before Lyme?
• Standard vs. extended courses of antibiotics for Lyme
• Hypothesis - 

Patients receiving extended treatment for Lyme:
• Symptomatic
• Seeking diagnosis for symptoms

Prior to the first Lyme diagnosis….
• To know the diagnostic journey towards a diagnosis of
Lyme disease
6
LD Case Definition
7
Claims data

2011-2012
LD Case Definition
7
Lyme 1
<30d
Lyme 2
ICD-9: 088.81 Lyme Disease
Diagnosis
Claims data

2011-2012
LD Case Definition
7
Lyme 1
<30d
Lyme 2
ICD-9: 088.81 Lyme Disease
Diagnosis
30d 30d
1 Drug Era
NDC, from IDSA, 9 antibiotics,

LD recorded date ± 30 d
+ Treatment
Claims data

2011-2012
LD Case Definition
7
Lyme 1
<30d
Lyme 2
ICD-9: 088.81 Lyme Disease
Diagnosis
30d 30d
1 Drug Era
NDC, from IDSA, 9 antibiotics,

LD recorded date ± 30 d
+ Treatment
CPT codes, 

LD recorded date ± 90 d
+ Lab orders
Claims data

2011-2012
LD Case Definition
8
Lyme 1
<30d
Lyme 2
ICD-9: 088.81 Lyme Disease
Diagnosis
30d 30d
1 Drug Era
NDC, from IDSA, 9 antibiotics,

LD recorded date ± 30 d
+ Treatment
CPT codes, 

LD recorded date ± 90 d
+ Lab orders
Claims data

2011-2012
Patients diagnosed with LD
and given extended
antibiotic therapy 

(PLDEA, Abx ≥5w)
Patients diagnosed with LD
and given standard
antibiotic therapy 

(PLDSA, Abx ≥2w and <5w)
The Diagnosis Journey
Before LD - 1/2
Claims data

2011-2012
9
The Diagnosis Journey
Before LD - 1/2
Claims data

2011-2012
First Lyme

Diagnosis
Continuously enrolled for ≥180d
9
The Diagnosis Journey
Before LD - 1/2
Claims data

2011-2012
First Lyme

Diagnosis
Continuously enrolled for ≥180d
Days before 

LD diagnosis
9
151-180 121-150 91-120 61-90 31-60 1-30
The Diagnosis Journey
Before LD - 1/2
Claims data

2011-2012
First Lyme

Diagnosis
Continuously enrolled for ≥180d
Days before 

LD diagnosis
Diagnosis categories 

(grouped by CCS)
Malaise
Joint pain
…
…
9
151-180 121-150 91-120 61-90 31-60 1-30
The Diagnosis Journey
Before LD - 1/2
Claims data

2011-2012
First Lyme

Diagnosis
Continuously enrolled for ≥180d
151-180 121-150 91-120 61-90 31-60 1-30
1 0 1 0 0 0
0 1 0 0 0 1
0 0 0 0 0 0
1 1 0 0 1 0
Days before 

LD diagnosis
Diagnosis categories 

(grouped by CCS)
Malaise
Joint pain
…
…
1: diagnosed with at least 1 ICD-9 code in the group
9
The Diagnosis Journey
Before LD - 1/2
Claims data

2011-2012
First Lyme

Diagnosis
Continuously enrolled for ≥180d
151-180 121-15- 91-120 61-90 31-60 1-30
151-180 121-15- 91-120 61-90 31-60 1-30
151-180 121-150 91-120 61-90 31-60 1-30
1 0 1 0 0 0
0 1 0 0 0 1
0 0 0 0 0 0
1 1 0 0 1 0
Every patients with LD
Days before 

LD diagnosis
Diagnosis categories 

(grouped by CCS)
Malaise
Joint pain
…
…
1: diagnosed with at least 1 ICD-9 code in the group
9
The Diagnosis Journey
Before LD - 2/2
10
151-18
0
121-15
-
91-120 61-90 31-60 1-30
151-18
0
121-15
-
91-120 61-90 31-60 1-30
151-180 121-150 91-120 61-90 31-60 1-30
1 0 1 0 0 0
0 1 0 0 0 1
0 0 0 0 0 0
1 1 0 0 1 0
Days before 

LD diagnosis
Every patients with PLDEA
Malaise
Joint pain
…
…
Patients diagnosed with LD and 

given extended antibiotic therapy 

(PLDEA, Abx ≥5w)
The Diagnosis Journey
Before LD - 2/2
10
151-18
0
121-15
-
91-120 61-90 31-60 1-30
151-18
0
121-15
-
91-120 61-90 31-60 1-30
151-180 121-150 91-120 61-90 31-60 1-30
1 0 1 0 0 0
0 1 0 0 0 1
0 0 0 0 0 0
1 1 0 0 1 0
Days before 

LD diagnosis
Every patients with PLDEA
Malaise
Joint pain
…
…
151-18
0
121-15
-
91-120 61-90 31-60 1-30
151-18
0
121-15
-
91-120 61-90 31-60 1-30
151-180 121-150 91-120 61-90 31-60 1-30
1 0 1 0 0 0
0 1 0 0 0 1
0 0 0 0 0 0
1 1 0 0 1 0
Days before 

LD diagnosis
Every patients with PLDSA
Malaise
Joint pain
…
…
Patients diagnosed with LD and 

given extended antibiotic therapy 

(PLDEA, Abx ≥5w)
Patients diagnosed with LD and

given standard antibiotic therapy 

(PLDSA, Abx ≥2w and <5w)
compared
with
The Diagnosis Journey
Before LD - 2/2
10
151-18
0
121-15
-
91-120 61-90 31-60 1-30
151-18
0
121-15
-
91-120 61-90 31-60 1-30
151-180 121-150 91-120 61-90 31-60 1-30
1 0 1 0 0 0
0 1 0 0 0 1
0 0 0 0 0 0
1 1 0 0 1 0
Days before 

LD diagnosis
Every patients with PLDEA
Malaise
Joint pain
…
…
151-18
0
121-15
-
91-120 61-90 31-60 1-30
151-18
0
121-15
-
91-120 61-90 31-60 1-30
151-180 121-150 91-120 61-90 31-60 1-30
1 0 1 0 0 0
0 1 0 0 0 1
0 0 0 0 0 0
1 1 0 0 1 0
Days before 

LD diagnosis
Every patients with PLDSA
Malaise
Joint pain
…
…
Patients diagnosed with LD and 

given extended antibiotic therapy 

(PLDEA, Abx ≥5w)
Patients diagnosed with LD and

given standard antibiotic therapy 

(PLDSA, Abx ≥2w and <5w)
compared
with
Logistic Regression
ORs
Demographic Characteristics and
Antibiotic Therapy of PLDSA & PLDEA
N (%)
Characteristic PLDEA PLDSA P value
Patients 600 3,207
Female 367 (61.2) 1,556 (48.5) <0.001
Age (years) 42.5 (17.9) 40.7 (19.9) <0.05
Diagnosed outside of
summer months
302 (50.3) 1,284 (40.0) <0.001
Most common antibiotic
Doxycycline
367 (61.2)
Doxycycline 

2497 (77.9)
Exposure days of antibiotic
Mean (SD) 73.9 (38.3) 23.0 (5.5)
Range (Min–Max) 35-315 14-34
Number of refills 2.7 (1.2) 1.2 (0.4) <0.001
11
Diagnostic Journeys of
PLDEA
8.5
7.8
9.7
9
11
9
5.2
9
5.5
9.2
6.7
14
10.2
10.2
13
10.8
13.8
20.8
18.8
13.5
10.3
23.7
9.5
Spondylosis, intervertebral disc disorders,
and other back problems
Other connective tissue disease
Other nervous system disorders
Malaise and fatigue
Non−traumatic joint disorders
Mental Illness
Headache, including migraine
Diseases of the skin and subcutaneous tissue
151−180
121−150
91−120
61−90
31−60
1−30
Before Lyme disease diagnosis, days
Diagnosticlabels
1.0
1.5
2.0
Adjusted
OR
12
Diagnostic Journeys of
PLDEA
8.5
7.8
9.7
9
11
9
5.2
9
5.5
9.2
6.7
14
10.2
10.2
13
10.8
13.8
20.8
18.8
13.5
10.3
23.7
9.5
Spondylosis, intervertebral disc disorders,
and other back problems
Other connective tissue disease
Other nervous system disorders
Malaise and fatigue
Non−traumatic joint disorders
Mental Illness
Headache, including migraine
Diseases of the skin and subcutaneous tissue
151−180
121−150
91−120
61−90
31−60
1−30
Before Lyme disease diagnosis, days
Diagnosticlabels
1.0
1.5
2.0
Adjusted
OR
12
Odds of mental illness in 

PLDEA compared with PLDSA
Diagnostic Journeys of
PLDEA
8.5
7.8
9.7
9
11
9
5.2
9
5.5
9.2
6.7
14
10.2
10.2
13
10.8
13.8
20.8
18.8
13.5
10.3
23.7
9.5
Spondylosis, intervertebral disc disorders,
and other back problems
Other connective tissue disease
Other nervous system disorders
Malaise and fatigue
Non−traumatic joint disorders
Mental Illness
Headache, including migraine
Diseases of the skin and subcutaneous tissue
151−180
121−150
91−120
61−90
31−60
1−30
Before Lyme disease diagnosis, days
Diagnosticlabels
1.0
1.5
2.0
Adjusted
OR
12
% of PLDEA patients

with mental illness
Diagnostic Journeys of
PLDEA
8.5
7.8
9.7
9
11
9
5.2
9
5.5
9.2
6.7
14
10.2
10.2
13
10.8
13.8
20.8
18.8
13.5
10.3
23.7
9.5
Spondylosis, intervertebral disc disorders,
and other back problems
Other connective tissue disease
Other nervous system disorders
Malaise and fatigue
Non−traumatic joint disorders
Mental Illness
Headache, including migraine
Diseases of the skin and subcutaneous tissue
151−180
121−150
91−120
61−90
31−60
1−30
Before Lyme disease diagnosis, days
Diagnosticlabels
1.0
1.5
2.0
Adjusted
OR
13
Diagnostic Journeys of
PLDEA
8.5
7.8
9.7
9
11
9
5.2
9
5.5
9.2
6.7
14
10.2
10.2
13
10.8
13.8
20.8
18.8
13.5
10.3
23.7
9.5
Spondylosis, intervertebral disc disorders,
and other back problems
Other connective tissue disease
Other nervous system disorders
Malaise and fatigue
Non−traumatic joint disorders
Mental Illness
Headache, including migraine
Diseases of the skin and subcutaneous tissue
151−180
121−150
91−120
61−90
31−60
1−30
Before Lyme disease diagnosis, days
Diagnosticlabels
1.0
1.5
2.0
Adjusted
OR
13
Diagnostic Journeys of
PLDEA
8.5
7.8
9.7
9
11
9
5.2
9
5.5
9.2
6.7
14
10.2
10.2
13
10.8
13.8
20.8
18.8
13.5
10.3
23.7
9.5
Spondylosis, intervertebral disc disorders,
and other back problems
Other connective tissue disease
Other nervous system disorders
Malaise and fatigue
Non−traumatic joint disorders
Mental Illness
Headache, including migraine
Diseases of the skin and subcutaneous tissue
151−180
121−150
91−120
61−90
31−60
1−30
Before Lyme disease diagnosis, days
Diagnosticlabels
1.0
1.5
2.0
Adjusted
OR
13
Diagnostic Journeys of
PLDEA
8.5
7.8
9.7
9
11
9
5.2
9
5.5
9.2
6.7
14
10.2
10.2
13
10.8
13.8
20.8
18.8
13.5
10.3
23.7
9.5
Spondylosis, intervertebral disc disorders,
and other back problems
Other connective tissue disease
Other nervous system disorders
Malaise and fatigue
Non−traumatic joint disorders
Mental Illness
Headache, including migraine
Diseases of the skin and subcutaneous tissue
151−180
121−150
91−120
61−90
31−60
1−30
Before Lyme disease diagnosis, days
Diagnosticlabels
1.0
1.5
2.0
Adjusted
OR
14
Summary
• Among PLDEA, 15.8% of them were symptomatic
and seeking care for several months prior to their
first LD diagnosis.
• These findings could be used to prospectively
identify and target patients likely to receive a LD
diagnosis several months hence.
15
@YiJuTseng http://yijutseng.github.io/
yjtseng@mail.cgu.edu.tw
YJ Tseng, et al. Claims-based Diagnostic Patterns of Patients Evaluated for
Lyme Disease and Given Extended Antibiotic Therapy. Vector-Borne and
Zoonotic Diseases. 2016 (In Press)

Weitere ähnliche Inhalte

Ähnlich wie Diagnostic Journeys of Patients Evaluated for Lyme Disease and Given Extended Antibiotic Therapy

Delirium in critically ill patients bogota043009
Delirium in critically ill patients bogota043009Delirium in critically ill patients bogota043009
Delirium in critically ill patients bogota043009
hospira2010
 
Prostate cancer nemrock 2015 sanofi
Prostate cancer nemrock 2015   sanofiProstate cancer nemrock 2015   sanofi
Prostate cancer nemrock 2015 sanofi
Mohamed Abdulla
 
Pm 4.50 hochberg
Pm 4.50 hochbergPm 4.50 hochberg
Pm 4.50 hochberg
plmiami
 
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 DuffusD1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
DSHS
 

Ähnlich wie Diagnostic Journeys of Patients Evaluated for Lyme Disease and Given Extended Antibiotic Therapy (20)

Clinical Impact of New HIV Data From the 2016 Comorbidities-Adverse Drug Reac...
Clinical Impact of New HIV Data From the 2016 Comorbidities-Adverse Drug Reac...Clinical Impact of New HIV Data From the 2016 Comorbidities-Adverse Drug Reac...
Clinical Impact of New HIV Data From the 2016 Comorbidities-Adverse Drug Reac...
 
Delirium in critically ill patients bogota043009
Delirium in critically ill patients bogota043009Delirium in critically ill patients bogota043009
Delirium in critically ill patients bogota043009
 
Risicomodel covid 19 E van der Vinne BeForced
Risicomodel covid 19 E van der Vinne BeForcedRisicomodel covid 19 E van der Vinne BeForced
Risicomodel covid 19 E van der Vinne BeForced
 
Jan-Malte Sinning: The role of pMCS – Which patients benefit from hemodynamic...
Jan-Malte Sinning: The role of pMCS – Which patients benefit from hemodynamic...Jan-Malte Sinning: The role of pMCS – Which patients benefit from hemodynamic...
Jan-Malte Sinning: The role of pMCS – Which patients benefit from hemodynamic...
 
Prostate cancer nemrock 2015 sanofi
Prostate cancer nemrock 2015   sanofiProstate cancer nemrock 2015   sanofi
Prostate cancer nemrock 2015 sanofi
 
AALL0932 protocol
AALL0932 protocolAALL0932 protocol
AALL0932 protocol
 
John Gallacher - What next
John Gallacher - What nextJohn Gallacher - What next
John Gallacher - What next
 
Pm 4.50 hochberg
Pm 4.50 hochbergPm 4.50 hochberg
Pm 4.50 hochberg
 
Resolute International 09.21
Resolute International 09.21Resolute International 09.21
Resolute International 09.21
 
Update on International CFAR Grant on Tuberculosis and HIV Screening in Healt...
Update on International CFAR Grant on Tuberculosis and HIV Screening in Healt...Update on International CFAR Grant on Tuberculosis and HIV Screening in Healt...
Update on International CFAR Grant on Tuberculosis and HIV Screening in Healt...
 
EUPHA
EUPHAEUPHA
EUPHA
 
Update on the 18th International Conference on Co-morbidities and Adverse Dru...
Update on the 18th International Conference on Co-morbidities and Adverse Dru...Update on the 18th International Conference on Co-morbidities and Adverse Dru...
Update on the 18th International Conference on Co-morbidities and Adverse Dru...
 
Sle an update_lfa_20151007
Sle an update_lfa_20151007Sle an update_lfa_20151007
Sle an update_lfa_20151007
 
Inflammation Persists Even During HIV Therapy
Inflammation Persists Even During HIV TherapyInflammation Persists Even During HIV Therapy
Inflammation Persists Even During HIV Therapy
 
Effortles Trial
Effortles TrialEffortles Trial
Effortles Trial
 
Austin Aging Research
Austin Aging Research Austin Aging Research
Austin Aging Research
 
"Toward Generating Domain-specific / Personalized Problem Lists from Electron...
"Toward Generating Domain-specific / Personalized Problem Lists from Electron..."Toward Generating Domain-specific / Personalized Problem Lists from Electron...
"Toward Generating Domain-specific / Personalized Problem Lists from Electron...
 
1120310-最新台灣高血壓治療指引.pdf
1120310-最新台灣高血壓治療指引.pdf1120310-最新台灣高血壓治療指引.pdf
1120310-最新台灣高血壓治療指引.pdf
 
Get into the Research
Get into the ResearchGet into the Research
Get into the Research
 
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 DuffusD1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
 

Kürzlich hochgeladen

If this Giant Must Walk: A Manifesto for a New Nigeria
If this Giant Must Walk: A Manifesto for a New NigeriaIf this Giant Must Walk: A Manifesto for a New Nigeria
If this Giant Must Walk: A Manifesto for a New Nigeria
Kayode Fayemi
 
No Advance 8868886958 Chandigarh Call Girls , Indian Call Girls For Full Nigh...
No Advance 8868886958 Chandigarh Call Girls , Indian Call Girls For Full Nigh...No Advance 8868886958 Chandigarh Call Girls , Indian Call Girls For Full Nigh...
No Advance 8868886958 Chandigarh Call Girls , Indian Call Girls For Full Nigh...
Sheetaleventcompany
 
Uncommon Grace The Autobiography of Isaac Folorunso
Uncommon Grace The Autobiography of Isaac FolorunsoUncommon Grace The Autobiography of Isaac Folorunso
Uncommon Grace The Autobiography of Isaac Folorunso
Kayode Fayemi
 

Kürzlich hochgeladen (20)

My Presentation "In Your Hands" by Halle Bailey
My Presentation "In Your Hands" by Halle BaileyMy Presentation "In Your Hands" by Halle Bailey
My Presentation "In Your Hands" by Halle Bailey
 
Dreaming Music Video Treatment _ Project & Portfolio III
Dreaming Music Video Treatment _ Project & Portfolio IIIDreaming Music Video Treatment _ Project & Portfolio III
Dreaming Music Video Treatment _ Project & Portfolio III
 
SaaStr Workshop Wednesday w/ Lucas Price, Yardstick
SaaStr Workshop Wednesday w/ Lucas Price, YardstickSaaStr Workshop Wednesday w/ Lucas Price, Yardstick
SaaStr Workshop Wednesday w/ Lucas Price, Yardstick
 
Re-membering the Bard: Revisiting The Compleat Wrks of Wllm Shkspr (Abridged)...
Re-membering the Bard: Revisiting The Compleat Wrks of Wllm Shkspr (Abridged)...Re-membering the Bard: Revisiting The Compleat Wrks of Wllm Shkspr (Abridged)...
Re-membering the Bard: Revisiting The Compleat Wrks of Wllm Shkspr (Abridged)...
 
Mohammad_Alnahdi_Oral_Presentation_Assignment.pptx
Mohammad_Alnahdi_Oral_Presentation_Assignment.pptxMohammad_Alnahdi_Oral_Presentation_Assignment.pptx
Mohammad_Alnahdi_Oral_Presentation_Assignment.pptx
 
Busty Desi⚡Call Girls in Sector 51 Noida Escorts >༒8448380779 Escort Service-...
Busty Desi⚡Call Girls in Sector 51 Noida Escorts >༒8448380779 Escort Service-...Busty Desi⚡Call Girls in Sector 51 Noida Escorts >༒8448380779 Escort Service-...
Busty Desi⚡Call Girls in Sector 51 Noida Escorts >༒8448380779 Escort Service-...
 
ANCHORING SCRIPT FOR A CULTURAL EVENT.docx
ANCHORING SCRIPT FOR A CULTURAL EVENT.docxANCHORING SCRIPT FOR A CULTURAL EVENT.docx
ANCHORING SCRIPT FOR A CULTURAL EVENT.docx
 
If this Giant Must Walk: A Manifesto for a New Nigeria
If this Giant Must Walk: A Manifesto for a New NigeriaIf this Giant Must Walk: A Manifesto for a New Nigeria
If this Giant Must Walk: A Manifesto for a New Nigeria
 
ICT role in 21st century education and it's challenges.pdf
ICT role in 21st century education and it's challenges.pdfICT role in 21st century education and it's challenges.pdf
ICT role in 21st century education and it's challenges.pdf
 
No Advance 8868886958 Chandigarh Call Girls , Indian Call Girls For Full Nigh...
No Advance 8868886958 Chandigarh Call Girls , Indian Call Girls For Full Nigh...No Advance 8868886958 Chandigarh Call Girls , Indian Call Girls For Full Nigh...
No Advance 8868886958 Chandigarh Call Girls , Indian Call Girls For Full Nigh...
 
BDSM⚡Call Girls in Sector 97 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 97 Noida Escorts >༒8448380779 Escort ServiceBDSM⚡Call Girls in Sector 97 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 97 Noida Escorts >༒8448380779 Escort Service
 
Call Girl Number in Khar Mumbai📲 9892124323 💞 Full Night Enjoy
Call Girl Number in Khar Mumbai📲 9892124323 💞 Full Night EnjoyCall Girl Number in Khar Mumbai📲 9892124323 💞 Full Night Enjoy
Call Girl Number in Khar Mumbai📲 9892124323 💞 Full Night Enjoy
 
lONG QUESTION ANSWER PAKISTAN STUDIES10.
lONG QUESTION ANSWER PAKISTAN STUDIES10.lONG QUESTION ANSWER PAKISTAN STUDIES10.
lONG QUESTION ANSWER PAKISTAN STUDIES10.
 
Causes of poverty in France presentation.pptx
Causes of poverty in France presentation.pptxCauses of poverty in France presentation.pptx
Causes of poverty in France presentation.pptx
 
Uncommon Grace The Autobiography of Isaac Folorunso
Uncommon Grace The Autobiography of Isaac FolorunsoUncommon Grace The Autobiography of Isaac Folorunso
Uncommon Grace The Autobiography of Isaac Folorunso
 
Air breathing and respiratory adaptations in diver animals
Air breathing and respiratory adaptations in diver animalsAir breathing and respiratory adaptations in diver animals
Air breathing and respiratory adaptations in diver animals
 
Report Writing Webinar Training
Report Writing Webinar TrainingReport Writing Webinar Training
Report Writing Webinar Training
 
The workplace ecosystem of the future 24.4.2024 Fabritius_share ii.pdf
The workplace ecosystem of the future 24.4.2024 Fabritius_share ii.pdfThe workplace ecosystem of the future 24.4.2024 Fabritius_share ii.pdf
The workplace ecosystem of the future 24.4.2024 Fabritius_share ii.pdf
 
AWS Data Engineer Associate (DEA-C01) Exam Dumps 2024.pdf
AWS Data Engineer Associate (DEA-C01) Exam Dumps 2024.pdfAWS Data Engineer Associate (DEA-C01) Exam Dumps 2024.pdf
AWS Data Engineer Associate (DEA-C01) Exam Dumps 2024.pdf
 
BDSM⚡Call Girls in Sector 93 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 93 Noida Escorts >༒8448380779 Escort ServiceBDSM⚡Call Girls in Sector 93 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 93 Noida Escorts >༒8448380779 Escort Service
 

Diagnostic Journeys of Patients Evaluated for Lyme Disease and Given Extended Antibiotic Therapy

  • 1. Diagnostic Journeys of Patients Evaluated for Lyme Disease and Given Extended Antibiotic Therapy Yi-Ju Tseng, PhD Computational Health Informatics Program (CHIP) Boston Children’s Hospital, MA, USA
 Dept. of Information Management, Chang Gung University, Taiwan Co-authors: 
 Alfred DeMaria Jr, Donald Goldmann, Kenneth Mandl* AMIA 2016 S59: Podium Presentations Using Data Science to address Clinical Problems
  • 2. Research Target 2 Nelson CA. et al (2015). Incidence of Clinician-Diagnosed Lyme Disease, United States, 2005–2010. Emerging Infectious Diseases, 21(9), 1625–1631
  • 3. Research Target 2 Nelson CA. et al (2015). Incidence of Clinician-Diagnosed Lyme Disease, United States, 2005–2010. Emerging Infectious Diseases, 21(9), 1625–1631 Only 25,000 reported cases in 2014
  • 4. 3
  • 5. Standard treatment: 
 2-4w antibiotic
 ↓
 Persistent Symptom
 ↓
 Post-treatment LD Syndrome 10~20% 4
  • 6. Standard treatment: 
 2-4w antibiotic
 ↓
 Persistent Symptom
 ↓
 Post-treatment LD Syndrome 10~20% 4
  • 7. Narrative Matte DOI: 10.1377/HLTHAFF.2011.0792 Chronic Lyme Disease: It’s Time To Solve The Medical Mystery Inside An Enigma Scientists and doctors disagree about whether there is such a condition as “chronic” Lyme disease or “post–Lyme disease syndrome.” Americans need the National Institutes of Health and basic science research to help determine the answer. BY LAURIE MCCLELLAN acc dis A Pat gra wa bac for pac pli har ma isti his car I mi he wa nap got the kep un G ho tim an six aro to fre wa wa T lat ing Nu it h wh Pat Jul Standard treatment: 
 2-4w antibiotic
 ↓
 Persistent Symptom
 ↓
 Post-treatment LD Syndrome 10~20% 4
  • 8.
  • 9. What Happens before Lyme? • Standard vs. extended courses of antibiotics for Lyme • Hypothesis - 
 Patients receiving extended treatment for Lyme: • Symptomatic • Seeking diagnosis for symptoms
 Prior to the first Lyme diagnosis…. • To know the diagnostic journey towards a diagnosis of Lyme disease 6
  • 10. LD Case Definition 7 Claims data
 2011-2012
  • 11. LD Case Definition 7 Lyme 1 <30d Lyme 2 ICD-9: 088.81 Lyme Disease Diagnosis Claims data
 2011-2012
  • 12. LD Case Definition 7 Lyme 1 <30d Lyme 2 ICD-9: 088.81 Lyme Disease Diagnosis 30d 30d 1 Drug Era NDC, from IDSA, 9 antibiotics,
 LD recorded date ± 30 d + Treatment Claims data
 2011-2012
  • 13. LD Case Definition 7 Lyme 1 <30d Lyme 2 ICD-9: 088.81 Lyme Disease Diagnosis 30d 30d 1 Drug Era NDC, from IDSA, 9 antibiotics,
 LD recorded date ± 30 d + Treatment CPT codes, 
 LD recorded date ± 90 d + Lab orders Claims data
 2011-2012
  • 14. LD Case Definition 8 Lyme 1 <30d Lyme 2 ICD-9: 088.81 Lyme Disease Diagnosis 30d 30d 1 Drug Era NDC, from IDSA, 9 antibiotics,
 LD recorded date ± 30 d + Treatment CPT codes, 
 LD recorded date ± 90 d + Lab orders Claims data
 2011-2012 Patients diagnosed with LD and given extended antibiotic therapy 
 (PLDEA, Abx ≥5w) Patients diagnosed with LD and given standard antibiotic therapy 
 (PLDSA, Abx ≥2w and <5w)
  • 15. The Diagnosis Journey Before LD - 1/2 Claims data
 2011-2012 9
  • 16. The Diagnosis Journey Before LD - 1/2 Claims data
 2011-2012 First Lyme
 Diagnosis Continuously enrolled for ≥180d 9
  • 17. The Diagnosis Journey Before LD - 1/2 Claims data
 2011-2012 First Lyme
 Diagnosis Continuously enrolled for ≥180d Days before 
 LD diagnosis 9 151-180 121-150 91-120 61-90 31-60 1-30
  • 18. The Diagnosis Journey Before LD - 1/2 Claims data
 2011-2012 First Lyme
 Diagnosis Continuously enrolled for ≥180d Days before 
 LD diagnosis Diagnosis categories 
 (grouped by CCS) Malaise Joint pain … … 9 151-180 121-150 91-120 61-90 31-60 1-30
  • 19. The Diagnosis Journey Before LD - 1/2 Claims data
 2011-2012 First Lyme
 Diagnosis Continuously enrolled for ≥180d 151-180 121-150 91-120 61-90 31-60 1-30 1 0 1 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 1 1 0 0 1 0 Days before 
 LD diagnosis Diagnosis categories 
 (grouped by CCS) Malaise Joint pain … … 1: diagnosed with at least 1 ICD-9 code in the group 9
  • 20. The Diagnosis Journey Before LD - 1/2 Claims data
 2011-2012 First Lyme
 Diagnosis Continuously enrolled for ≥180d 151-180 121-15- 91-120 61-90 31-60 1-30 151-180 121-15- 91-120 61-90 31-60 1-30 151-180 121-150 91-120 61-90 31-60 1-30 1 0 1 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 1 1 0 0 1 0 Every patients with LD Days before 
 LD diagnosis Diagnosis categories 
 (grouped by CCS) Malaise Joint pain … … 1: diagnosed with at least 1 ICD-9 code in the group 9
  • 21. The Diagnosis Journey Before LD - 2/2 10 151-18 0 121-15 - 91-120 61-90 31-60 1-30 151-18 0 121-15 - 91-120 61-90 31-60 1-30 151-180 121-150 91-120 61-90 31-60 1-30 1 0 1 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 1 1 0 0 1 0 Days before 
 LD diagnosis Every patients with PLDEA Malaise Joint pain … … Patients diagnosed with LD and 
 given extended antibiotic therapy 
 (PLDEA, Abx ≥5w)
  • 22. The Diagnosis Journey Before LD - 2/2 10 151-18 0 121-15 - 91-120 61-90 31-60 1-30 151-18 0 121-15 - 91-120 61-90 31-60 1-30 151-180 121-150 91-120 61-90 31-60 1-30 1 0 1 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 1 1 0 0 1 0 Days before 
 LD diagnosis Every patients with PLDEA Malaise Joint pain … … 151-18 0 121-15 - 91-120 61-90 31-60 1-30 151-18 0 121-15 - 91-120 61-90 31-60 1-30 151-180 121-150 91-120 61-90 31-60 1-30 1 0 1 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 1 1 0 0 1 0 Days before 
 LD diagnosis Every patients with PLDSA Malaise Joint pain … … Patients diagnosed with LD and 
 given extended antibiotic therapy 
 (PLDEA, Abx ≥5w) Patients diagnosed with LD and
 given standard antibiotic therapy 
 (PLDSA, Abx ≥2w and <5w) compared with
  • 23. The Diagnosis Journey Before LD - 2/2 10 151-18 0 121-15 - 91-120 61-90 31-60 1-30 151-18 0 121-15 - 91-120 61-90 31-60 1-30 151-180 121-150 91-120 61-90 31-60 1-30 1 0 1 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 1 1 0 0 1 0 Days before 
 LD diagnosis Every patients with PLDEA Malaise Joint pain … … 151-18 0 121-15 - 91-120 61-90 31-60 1-30 151-18 0 121-15 - 91-120 61-90 31-60 1-30 151-180 121-150 91-120 61-90 31-60 1-30 1 0 1 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 1 1 0 0 1 0 Days before 
 LD diagnosis Every patients with PLDSA Malaise Joint pain … … Patients diagnosed with LD and 
 given extended antibiotic therapy 
 (PLDEA, Abx ≥5w) Patients diagnosed with LD and
 given standard antibiotic therapy 
 (PLDSA, Abx ≥2w and <5w) compared with Logistic Regression ORs
  • 24. Demographic Characteristics and Antibiotic Therapy of PLDSA & PLDEA N (%) Characteristic PLDEA PLDSA P value Patients 600 3,207 Female 367 (61.2) 1,556 (48.5) <0.001 Age (years) 42.5 (17.9) 40.7 (19.9) <0.05 Diagnosed outside of summer months 302 (50.3) 1,284 (40.0) <0.001 Most common antibiotic Doxycycline 367 (61.2) Doxycycline 
 2497 (77.9) Exposure days of antibiotic Mean (SD) 73.9 (38.3) 23.0 (5.5) Range (Min–Max) 35-315 14-34 Number of refills 2.7 (1.2) 1.2 (0.4) <0.001 11
  • 25. Diagnostic Journeys of PLDEA 8.5 7.8 9.7 9 11 9 5.2 9 5.5 9.2 6.7 14 10.2 10.2 13 10.8 13.8 20.8 18.8 13.5 10.3 23.7 9.5 Spondylosis, intervertebral disc disorders, and other back problems Other connective tissue disease Other nervous system disorders Malaise and fatigue Non−traumatic joint disorders Mental Illness Headache, including migraine Diseases of the skin and subcutaneous tissue 151−180 121−150 91−120 61−90 31−60 1−30 Before Lyme disease diagnosis, days Diagnosticlabels 1.0 1.5 2.0 Adjusted OR 12
  • 26. Diagnostic Journeys of PLDEA 8.5 7.8 9.7 9 11 9 5.2 9 5.5 9.2 6.7 14 10.2 10.2 13 10.8 13.8 20.8 18.8 13.5 10.3 23.7 9.5 Spondylosis, intervertebral disc disorders, and other back problems Other connective tissue disease Other nervous system disorders Malaise and fatigue Non−traumatic joint disorders Mental Illness Headache, including migraine Diseases of the skin and subcutaneous tissue 151−180 121−150 91−120 61−90 31−60 1−30 Before Lyme disease diagnosis, days Diagnosticlabels 1.0 1.5 2.0 Adjusted OR 12 Odds of mental illness in 
 PLDEA compared with PLDSA
  • 27. Diagnostic Journeys of PLDEA 8.5 7.8 9.7 9 11 9 5.2 9 5.5 9.2 6.7 14 10.2 10.2 13 10.8 13.8 20.8 18.8 13.5 10.3 23.7 9.5 Spondylosis, intervertebral disc disorders, and other back problems Other connective tissue disease Other nervous system disorders Malaise and fatigue Non−traumatic joint disorders Mental Illness Headache, including migraine Diseases of the skin and subcutaneous tissue 151−180 121−150 91−120 61−90 31−60 1−30 Before Lyme disease diagnosis, days Diagnosticlabels 1.0 1.5 2.0 Adjusted OR 12 % of PLDEA patients with mental illness
  • 28. Diagnostic Journeys of PLDEA 8.5 7.8 9.7 9 11 9 5.2 9 5.5 9.2 6.7 14 10.2 10.2 13 10.8 13.8 20.8 18.8 13.5 10.3 23.7 9.5 Spondylosis, intervertebral disc disorders, and other back problems Other connective tissue disease Other nervous system disorders Malaise and fatigue Non−traumatic joint disorders Mental Illness Headache, including migraine Diseases of the skin and subcutaneous tissue 151−180 121−150 91−120 61−90 31−60 1−30 Before Lyme disease diagnosis, days Diagnosticlabels 1.0 1.5 2.0 Adjusted OR 13
  • 29. Diagnostic Journeys of PLDEA 8.5 7.8 9.7 9 11 9 5.2 9 5.5 9.2 6.7 14 10.2 10.2 13 10.8 13.8 20.8 18.8 13.5 10.3 23.7 9.5 Spondylosis, intervertebral disc disorders, and other back problems Other connective tissue disease Other nervous system disorders Malaise and fatigue Non−traumatic joint disorders Mental Illness Headache, including migraine Diseases of the skin and subcutaneous tissue 151−180 121−150 91−120 61−90 31−60 1−30 Before Lyme disease diagnosis, days Diagnosticlabels 1.0 1.5 2.0 Adjusted OR 13
  • 30. Diagnostic Journeys of PLDEA 8.5 7.8 9.7 9 11 9 5.2 9 5.5 9.2 6.7 14 10.2 10.2 13 10.8 13.8 20.8 18.8 13.5 10.3 23.7 9.5 Spondylosis, intervertebral disc disorders, and other back problems Other connective tissue disease Other nervous system disorders Malaise and fatigue Non−traumatic joint disorders Mental Illness Headache, including migraine Diseases of the skin and subcutaneous tissue 151−180 121−150 91−120 61−90 31−60 1−30 Before Lyme disease diagnosis, days Diagnosticlabels 1.0 1.5 2.0 Adjusted OR 13
  • 31. Diagnostic Journeys of PLDEA 8.5 7.8 9.7 9 11 9 5.2 9 5.5 9.2 6.7 14 10.2 10.2 13 10.8 13.8 20.8 18.8 13.5 10.3 23.7 9.5 Spondylosis, intervertebral disc disorders, and other back problems Other connective tissue disease Other nervous system disorders Malaise and fatigue Non−traumatic joint disorders Mental Illness Headache, including migraine Diseases of the skin and subcutaneous tissue 151−180 121−150 91−120 61−90 31−60 1−30 Before Lyme disease diagnosis, days Diagnosticlabels 1.0 1.5 2.0 Adjusted OR 14
  • 32. Summary • Among PLDEA, 15.8% of them were symptomatic and seeking care for several months prior to their first LD diagnosis. • These findings could be used to prospectively identify and target patients likely to receive a LD diagnosis several months hence. 15
  • 33. @YiJuTseng http://yijutseng.github.io/ yjtseng@mail.cgu.edu.tw YJ Tseng, et al. Claims-based Diagnostic Patterns of Patients Evaluated for Lyme Disease and Given Extended Antibiotic Therapy. Vector-Borne and Zoonotic Diseases. 2016 (In Press)